Blue Horseshoe Stocks: BBRY Recap, AEMD & More

Blackberry Ltd. BBRY – Options Review

We were very confident in the options ideas we formulated for BBRY in yesterday’s premarket report, which were the BBRY Weekly $9.50 & $10 Calls.  We pointed to the company’s convincing earnings beat as being the reason we felt a solid move was in order, despite the fact that it had just been hanging around the $9 area without a lot of volatility for the preceding few weeks.

A solid move is exactly what we got, with BBRY stock running from 9.78 to 10.83 on the day. That facilitated some fantastic gain opportunities for anyone who was following along with our ideas, which both produced multi-bag intraday upswings.

The $9.50 Calls traded in a range from .37-1.26 for a gain of 240%, while the $10′s ripped extremely hard from a low of .12 all the way up to .76. That worked out to an increase of 533% marking the second consecutive week where we’ve alerted on an options idea and seen a single-session gain of over 500% (KMX, last Friday).

Important Note: Never trade options with a weekly expiration on a Friday unless you’re an expert trader with disposable funds. It’s extremely risky.


Aethlon Medical, Inc. AEMD

The other top performer from yesterday’s premarket newsletter was AEMD, which, as you can see from the included chart snapshot, we alerted at the absolute perfect time. The stock had practically been in free-fall over the past couple of weeks, and we signaled the bottom with precision.

It traded in a range from 1.18 to 1.70, for a respectable intraday increase of 44% and closed at the high of day. This is a stock that was trading at nearly $4 just this month, and now we’re going to be monitoring to see how much of that ground it can recapture on the rebound. We’ll look for it to establish higher highs and higher lows. If it can manage to crack through the channel between the current 50DMA of 1.75 and September 11th’s swing high of 2.00, things could once again get very interesting for AEMD.


Extended Watchlist:
HMNY, VERI, ADHD, CONN, ZYNE, VKTX, DOLV

Blue Horseshoe Stocks: AAPL Review & More

Apple, Inc. AAPL – Options Review

We’re now mentioning the calls we made for the Apple options chain on Tuesday for the third consecutive day, after each of our tracked contracts yet again set new highs during yesterday’s session.

To refresh your memory, we slated the AAPL Weekly $150-155 Calls for observation in Tuesday’s premarket report, and they provided solid gain opportunities ranging from 78-146% that day.

Here are the updated figures showing the lows from Tuesday, to the new highs attained yesterday.

$150 Calls – Range: 2.30-4.80 – Max Gain: 109%
$152.50 Calls – Range: 1.00-2.55 – Max Gain: 155%.
$155 Calls – Range: .28-.89 – Max Gain: 218%



Fresh Options Ideas


While we’re on roll with options calls, we might as well let it ride by selecting a couple of other ideas that are worth monitoring.

Tiffany & Co. TIF - Tiffany’s chart is showing a decent bottom setup, while some insider buying was reported this week near 4-month lows. We’re going to highlight the TIF 10/20 $92-93 Calls and keep them on our radars in the days and weeks ahead.

Blackberry Ltd. BBRY - For a more short-term idea, we’re going to signal the BBRY Weekly $9.50 & $10 Calls on the heels of Blackberry’s premarket earning beat. Prior to today, the stock has hovering around a solid level of support at roughly $9 for quite some time, but today’s release could definitely have a positive effect on the chart. The company posted a beat on profits and revenue, while software sales set company records.


Extended Watchlist:
ZYNE, ADHD, IZEA, CHFS, AQMS, GALE, OPGN, AEMD, VTGN

Blue Horseshoe Stocks: AAPL Options & More

Apple, Inc. AAPL  – Options Idea

If you root through the seven year newsletter history archived at our website, BlueHorseshoeStocks.com, you would find that we’ve discussed AAPL more times than most stocks, even though we haven’t mentioned it much in recent times.

In fact, AAPL’s was the first go-to options chain that we focused on when we began including options trading ideas a few years ago. This morning, we’re coming back to this old favorite with a fresh idea to coincide with the current Apple hype.

The company is rolling out the new iPhone today, among other things, and iPhone announcements have historically provided some good ammunition for options traders. Today, we’re going to slate the AAPL Weekly $160 & $162.50 Calls for observation in forthcoming sessions as AAPL’s event is expected to drive up activity not only in its own stocks, but likely other tech stocks as well.


FutureLand Corp. FUTL

On Friday morning, we included FUTL in our watchlist, and the stock has made a solid two-swing for us. From Friday’s low of .0012 the stock set a new high of .0026 to kick off the week yesterday, which works out to an overall jump of 117% Yesterday’s big push came on volume of more than three times the monthly average.

We would also include a note of caution in terms of long term interest in this stock. The company dropped the news that it had entered into a joint venture with Greenleaf Holdings  that would “deliver solar technology to the cannabis industry”. Yet here it is, two months later, and there have been no further details given. We tend to be wary of companies that don’t keep a steady line of communication to shareholders.

That being said, we have seen some really nice movement on the chart as we mentioned above, so we’ll continue to keep an eye on FUTL.


Extended Watchlist:
ALDX, AEMD, CTIC, FRTA, HTBX, QTNT, OPGN, TA

Blue Horseshoe Stocks: Update on AEMD & More

Aethlon Medical, Inc. AEMD

Yesterday’s standout play was AEMD, a stock that we’ve been tracking since October 14th. Following that initial alert, we observed a low of .20 in AEMD, and after trading sideways for the remainder of last month, the stock has been gaining ground steadily over the past few weeks.

We re-flagged it in yesterday’s extended watchlist and witnessed a 27% intraday run from .562-.717 on approximately 10X the 3-month average trading volume. At its high mark of .717, AEMD was showing us an increase of 258% over the lows we observed barely a month ago.

The event that prompted us to originally begin following AEMD was during the height of the Ebola scare, when the company announced that its “Hemopurifier” blood-cleansing system was to be used to treat an Ebola patient overseas. This morning, we ‘re getting word that the patient (who was experiencing multiple organ failure at the time the treatment was administered) has now been discharged from the hospital. >>> FULL PR

It will be interesting to see the effect this news has on AEMD as we approach the holiday hiatus, which shortens this to a 3½ day trading week.


Petroleo Brasiliero S.A. (Petrobras) PBR -Options

PBR is gapping up again this morning, in the wake of yesterday’s announcement that its ‘Cidade de Ilhabela’ offshore oil platform had been brought online. (Read our comments on the company’s situation in yesterday’s report if you missed it)

Anyone who caught yesterday’s morning report will recall our options-trading targets; we were considering the Jan 17th $10 and $11 Calls. The gap-and-fade that followed provided us a good opportunity to snap up some discounted contracts, and we’ll be looking to lock in some profits on the gap-up we’re seeing this morning.


SinoCoking Coal and Coke Chemical Industries, Inc. SCOK

Another play that we’ve been monitoring for some time is SCOK, which we’ll want to watch closely today on the heels of a notable PR released this morning. According to SCOK, the syngas plant that it recently opened in China is now operating at 100% capacity and pulling more than $80K worth of syngas from the Earth per day.

We actually began tracking SCOK the morning it announced its intent to open the facility, (it ran hard that day from 3.35-9.37, +180%) so this morning’s PR regarding the plant acheiving full operational status brings us full circle with SCOK.

PINGDINGSHAN, China, Nov. 25, 2014 (GLOBE NEWSWIRE) — SinoCoking Coal and Coke Chemical Industries, Inc. (SCOK), a producer of clean energy products located in Henan Province, today announced that its above ground facility for the conversion of carbon dioxide into clean-burning syngas has achieved its initial production target of 25,000 cubic meters per hour and is currently transporting syngas to three customers and agents in and around its facility in Pingdingshan.

Based on the current price of $0.139 per cubic meter for syngas, the gross revenue generated per day by the aboveground facility is approximately $83,280. Gross profit margin is expected to be between 45% and 50%. >> FULL PR


Extended Watchlist:
ISNS, LAKE, CAMT, DRWI, LIVE

Blue Horseshoe Stocks: Commenting on PBR & More

Petroleo Brasiliero S.A. (Petrobras) PBR

Amid allegations of money-laundering and bribery which extend high up into the Brazilian government (including former PBR board member and President Dilma Rousseff) the sixth-largest energy company in the world, and a point of focus for us all year, could be forced to write down billions in assets and reduce dividends. The company’s Q3 financials are being delayed indefinitely as a result.

The long-term implications of such a scandal are too vast and varied for us to make even a brief assessment accurately. What we can do is stay extra tuned to the PBR newsfeed to stay as up-to-date as possible on current events and adhere to our technicals, because we can still see potential on the chart.

On Tuesday, PBR hit its all-time low of 8.80. but has since made higher lows and higher highs over the proceeding sessions. After we tagged it on Friday morning, there was a 9% intraday move from 10.08 to $11, and this morning the premarket high is 11.51, which will act as immediate resistance as the session kicks off. We’ll want to see support hold at roughly 10.85, but if PBR can break past this morning’s high to confirm its continued uptrend, the next thing we’d be looking for is the filling of a gap on the chart from approximately $12-12.50.

As far as options go, we’re presently looking at the Jan 17th $10 and $11 Calls, provided the current trend continues.


Prosensa Holdings (N.V.) RNA

RNA is a stock that we tracking periodically this spring and summer, and we just wanted to comment quickly on the buyout offer the company announced this morning. In a $680M deal, Prosensa will receive around $17.75/share from buyer BioMarin Pharmaceutical.

Following an alert we put out on RNA back in May, the stock was trading at a low of 7.96; this morning’s premarket high of $19 means we’ve seen more than a 130% move in this play over a span of about 5 months.


Extended Watchlist:
MOLG, GERN, CIMT, SYN, AEMD, MY